| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/21/2010 | EP2175883A2 Chimeric varicella zoster virus-virus like particles |
| 04/21/2010 | EP2175882A1 Varicella zoster virus-virus like particles (vlps) and antigens |
| 04/21/2010 | EP2175881A1 Intradermal influenza vaccine |
| 04/21/2010 | EP2175880A1 Inactivated staphylococcal whole-cell vaccine |
| 04/21/2010 | EP2175879A1 Treatment of prion protein related diseases |
| 04/21/2010 | EP2175878A1 Polymeric drug delivery system containing a multi-substituted aromatic moiety |
| 04/21/2010 | EP2175835A1 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 04/21/2010 | EP1689782B1 Anti-igfr1 antibody therapeutic combinations |
| 04/21/2010 | EP1519945B1 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1887351B Hepatitis B preventing vaccine and its preparation method |
| 04/21/2010 | CN1843507B Mumps virus ingredient vaccine for human, and its preparation method and uses |
| 04/21/2010 | CN1711096B Botulinum toxin formulations for oral administration |
| 04/21/2010 | CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof |
| 04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 04/21/2010 | CN101696242A Human anti rabies virus neutralizing antibody Fab as well as preparation method and application thereof |
| 04/21/2010 | CN101696239A Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof |
| 04/21/2010 | CN101695574A Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/21/2010 | CN101695573A Method for producing pseudorabies living vaccines by using subculture cell source and product thereof |
| 04/21/2010 | CN101695572A Method for producing pseudorabies attenuated vaccine by using bioreactor and pseudorabies attenuated vaccine product |
| 04/21/2010 | CN101695571A Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product |
| 04/21/2010 | CN101695570A Univalent and bivalent inactivated vaccine for hand-foot-and-mouth disease and preparation method thereof |
| 04/21/2010 | CN101695569A Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof |
| 04/21/2010 | CN101695568A A-type clostridium perfringens populus skin lipoid inactivated vaccine and preparation method thereof |
| 04/21/2010 | CN101695567A Water-in-oil type nanoemulsion vaccine preparation |
| 04/20/2010 | USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700743 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700738 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 04/20/2010 | US7700735 High potency recombinant antibodies and method for producing them |
| 04/20/2010 | US7700730 Using viral capsid protein comprising RGD domain (arginine-glycine-aspartic acid) to treat and prevent cell proliferative, nervous system, autoimmune and allergic disorders |
| 04/20/2010 | US7700726 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 04/20/2010 | US7700725 HIV antisense proteins |
| 04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 04/20/2010 | US7700720 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700615 comprises 4-methyl-3-nitro-benzoic acid as inhibitor and 1,3-bis(2-chloroethyl)-1-nitrosourea as chemotherapeutic agent; for treatment of breast cancer and melanomas |
| 04/20/2010 | US7700556 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 04/20/2010 | US7700555 Methods of treating diabetes |
| 04/20/2010 | US7700553 Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization |
| 04/20/2010 | US7700361 Secretory or membrane protein expressed in skeletal muscles |
| 04/20/2010 | US7700350 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion |
| 04/20/2010 | US7700344 Vector that produces a fusion protein of an antigen with a Listerial truncated ActA protein; use making vaccines |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700302 Method for generating and selecting antibodies against target protein |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700273 Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor |
| 04/20/2010 | US7700121 Gene associated with leishmania parasite virulence |
| 04/20/2010 | US7700120 Adjuvancy and immune potentiating properties of natural products of Onchocerca volvulus |
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700118 Molecular differences between species of the M. tuberculosis complex |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane |
| 04/20/2010 | US7700115 immunogens, tripeptides, pentapeptides; inducing antibodies against diverse HIV clades and relate to ability to identify HIV gp120-derived short peptide sequence immunogens; Alzheimer's disease, psoriasis, multiple sclerosis |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700111 Administering neurotrophin and continuous electrical stimulation to spiral ganglion cells to maintain cell viability and to restore hearing |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700108 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/20/2010 | US7700105 Methods of inducing IL-10 production |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700103 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 04/20/2010 | US7700102 Stimulant immunology response; prevent infections |
| 04/20/2010 | US7700101 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700099 Non-immunostimulatory antibody and compositions containing the same |
| 04/20/2010 | US7700098 autoimmune or an inflammatory disorders as Crohn's Disease, systemic lupus erythematosus, psoriasis, sarcoidosis, rheumatoid arthritis, vasculitis, atopic dermatitis and secondary progressive multiple sclerosis |
| 04/20/2010 | US7700097 Purification and preferential synthesis of binding molecules |
| 04/20/2010 | US7700096 Medicinal agent for treating erectile dysfunction |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2352572C Humanized antibodies to gamma-interferon |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2179779C Vaccine compositions comprising oil in water emulsions with tocopherol and squalene |
| 04/20/2010 | CA2166208C Phosphazene polyelectrolytes as immunoadjuvants |
| 04/20/2010 | CA2155303C Treatment for insulin dependent diabetes |
| 04/15/2010 | WO2010042942A2 Biochemically stabilized hiv-1 env trimer vaccine |
| 04/15/2010 | WO2010042919A2 Method of making a vaccine |
| 04/15/2010 | WO2010042876A1 Targeting of antigen presenting cells with immunonanotherapeutics |
| 04/15/2010 | WO2010042870A1 Adjuvant incorporation in immunonanotherapeutics |
| 04/15/2010 | WO2010042866A1 Nicotine immunonanotherapeutics |
| 04/15/2010 | WO2010042863A1 IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN |
| 04/15/2010 | WO2010042817A1 Use of hiv mosaic envelope proteins to optimize t-cell responses against hiv envelope |
| 04/15/2010 | WO2010042760A2 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 04/15/2010 | WO2010042743A2 Chimeric multiplexes, compositions, and methods for using same |
| 04/15/2010 | WO2010042705A1 Antibody formulation |
| 04/15/2010 | WO2010042697A1 Regulation of lymphocytes and uses therefor |